Stay updated on Durvalumab/Tremelumab ± Lenvatinib +TACE in HCC Clinical Trial

Sign up to get notified when there's something new on the Durvalumab/Tremelumab ± Lenvatinib +TACE in HCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab/Tremelumab ± Lenvatinib +TACE in HCC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    A new revision entry (v3.4.3) was added to the history and the previous revision (v3.4.2) was removed.
    Difference
    0.1%
    Check dated 2026-03-11T17:56:16.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 to the page. The government funding status notice and the prior Revision: v3.4.1 were removed.
    Difference
    0.6%
    Check dated 2026-02-11T06:16:46.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The history shows an added government-funding notice and a new revision tag (v3.4.1) replacing v3.4.0, which are minor metadata updates to the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.6%
    Check dated 2026-02-04T04:42:34.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    UI improvements include a 'Show glossary' option and explanatory notes that additions and deletions are color-coded in the history view, plus a revision note updating to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.8%
    Check dated 2026-01-28T03:10:42.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The page history now includes a new revision entry (v3.3.4) and removes the previous revision (v3.3.3). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:49:14.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Added a new record history entry 'Revision: v3.3.3' and removed 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' from the page footer. These are minor administrative updates that do not alter study information or how users interact with the page.
    Difference
    0.2%
    Check dated 2025-12-23T09:46:51.000Z thumbnail image

Stay in the know with updates to Durvalumab/Tremelumab ± Lenvatinib +TACE in HCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab/Tremelumab ± Lenvatinib +TACE in HCC Clinical Trial page.